Logo image of ELV

ELEVANCE HEALTH INC (ELV) Stock Fundamental Analysis

NYSE:ELV - US0367521038 - Common Stock

316.21 USD
+9.46 (+3.08%)
Last: 9/11/2025, 11:19:07 AM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to ELV. ELV was compared to 101 industry peers in the Health Care Providers & Services industry. While ELV is still in line with the averages on profitability rating, there are concerns on its financial health. ELV is not valued too expensively and it also shows a decent growth rate. Finally ELV also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year ELV was profitable.
In the past year ELV had a positive cash flow from operations.
ELV had positive earnings in each of the past 5 years.
In the past 5 years ELV always reported a positive cash flow from operatings.
ELV Yearly Net Income VS EBIT VS OCF VS FCFELV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

1.2 Ratios

ELV has a Return On Assets of 4.40%. This is in the better half of the industry: ELV outperforms 75.25% of its industry peers.
ELV has a Return On Equity of 12.26%. This is in the better half of the industry: ELV outperforms 77.23% of its industry peers.
The Return On Invested Capital of ELV (5.90%) is better than 62.38% of its industry peers.
ELV had an Average Return On Invested Capital over the past 3 years of 6.90%. This is below the industry average of 9.19%.
Industry RankSector Rank
ROA 4.4%
ROE 12.26%
ROIC 5.9%
ROA(3y)5.45%
ROA(5y)5.58%
ROE(3y)15.32%
ROE(5y)15.33%
ROIC(3y)6.9%
ROIC(5y)7.19%
ELV Yearly ROA, ROE, ROICELV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

The Profit Margin of ELV (2.83%) is better than 65.35% of its industry peers.
ELV's Profit Margin has declined in the last couple of years.
ELV has a Operating Margin of 4.60%. This is comparable to the rest of the industry: ELV outperforms 59.41% of its industry peers.
In the last couple of years the Operating Margin of ELV has declined.
Industry RankSector Rank
OM 4.6%
PM (TTM) 2.83%
GM N/A
OM growth 3Y-7.78%
OM growth 5Y-4.45%
PM growth 3Y-8.42%
PM growth 5Y-6.01%
GM growth 3YN/A
GM growth 5YN/A
ELV Yearly Profit, Operating, Gross MarginsELV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ELV is destroying value.
ELV has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, ELV has less shares outstanding
Compared to 1 year ago, ELV has a worse debt to assets ratio.
ELV Yearly Shares OutstandingELV Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
ELV Yearly Total Debt VS Total AssetsELV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B 100B

2.2 Solvency

The Debt to FCF ratio of ELV is 5.70, which is a neutral value as it means it would take ELV, 5.70 years of fcf income to pay off all of its debts.
With a decent Debt to FCF ratio value of 5.70, ELV is doing good in the industry, outperforming 64.36% of the companies in the same industry.
ELV has a Debt/Equity ratio of 0.65. This is a neutral value indicating ELV is somewhat dependend on debt financing.
ELV has a Debt to Equity ratio (0.65) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.65
Debt/FCF 5.7
Altman-Z N/A
ROIC/WACC0.73
WACC8.1%
ELV Yearly LT Debt VS Equity VS FCFELV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
ELV Yearly Current Assets VS Current LiabilitesELV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

5

3. Growth

3.1 Past

ELV shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -6.64%.
Measured over the past years, ELV shows a quite strong growth in Earnings Per Share. The EPS has been growing by 11.17% on average per year.
Looking at the last year, ELV shows a quite strong growth in Revenue. The Revenue has grown by 10.21% in the last year.
ELV shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 11.14% yearly.
EPS 1Y (TTM)-6.64%
EPS 3Y8.28%
EPS 5Y11.17%
EPS Q2Q%-12.65%
Revenue 1Y (TTM)10.21%
Revenue growth 3Y8.44%
Revenue growth 5Y11.14%
Sales Q2Q%14.34%

3.2 Future

ELV is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 8.79% yearly.
ELV is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.96% yearly.
EPS Next Y-8.42%
EPS Next 2Y-1.7%
EPS Next 3Y3.63%
EPS Next 5Y8.79%
Revenue Next Year12.27%
Revenue Next 2Y8.86%
Revenue Next 3Y7.89%
Revenue Next 5Y8.96%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
ELV Yearly Revenue VS EstimatesELV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 50B 100B 150B 200B 250B
ELV Yearly EPS VS EstimatesELV Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 20 40 60

6

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 9.58, the valuation of ELV can be described as very reasonable.
Based on the Price/Earnings ratio, ELV is valued cheaper than 92.08% of the companies in the same industry.
ELV's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.03.
A Price/Forward Earnings ratio of 9.93 indicates a reasonable valuation of ELV.
87.13% of the companies in the same industry are more expensive than ELV, based on the Price/Forward Earnings ratio.
ELV is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.54, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 9.58
Fwd PE 9.93
ELV Price Earnings VS Forward Price EarningsELV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ELV is valued a bit cheaper than the industry average as 77.23% of the companies are valued more expensively.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of ELV indicates a rather cheap valuation: ELV is cheaper than 82.18% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 13.46
EV/EBITDA 8.87
ELV Per share dataELV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 200 400 600 800

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)0.86
EPS Next 2Y-1.7%
EPS Next 3Y3.63%

7

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 2.22%, ELV has a reasonable but not impressive dividend return.
In the last 3 months the price of ELV has falen by -20.23%. A price decline artificially increases the dividend yield. It may be a sign investors do not expect the dividend to last.
ELV's Dividend Yield is rather good when compared to the industry average which is at 2.48. ELV pays more dividend than 92.08% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.45, ELV has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.22%

5.2 History

The dividend of ELV is nicely growing with an annual growth rate of 15.34%!
ELV has been paying a dividend for at least 10 years, so it has a reliable track record.
ELV has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)15.34%
Div Incr Years13
Div Non Decr Years13
ELV Yearly Dividends per shareELV Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6

5.3 Sustainability

ELV pays out 28.40% of its income as dividend. This is a sustainable payout ratio.
ELV's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP28.4%
EPS Next 2Y-1.7%
EPS Next 3Y3.63%
ELV Yearly Income VS Free CF VS DividendELV Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B
ELV Dividend Payout.ELV Dividend Payout, showing the Payout Ratio.ELV Dividend Payout.PayoutRetained Earnings

ELEVANCE HEALTH INC

NYSE:ELV (9/11/2025, 11:19:07 AM)

316.21

+9.46 (+3.08%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)07-17 2025-07-17/bmo
Earnings (Next)10-15 2025-10-15/amc
Inst Owners94.98%
Inst Owner ChangeN/A
Ins Owners0.13%
Ins Owner Change2.72%
Market Cap71.20B
Analysts76.43
Price Target371.62 (17.52%)
Short Float %1.4%
Short Ratio1.23
Dividend
Industry RankSector Rank
Dividend Yield 2.22%
Yearly Dividend6.55
Dividend Growth(5Y)15.34%
DP28.4%
Div Incr Years13
Div Non Decr Years13
Ex-Date09-10 2025-09-10 (1.71)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.93%
Min EPS beat(2)-2.26%
Max EPS beat(2)4.12%
EPS beat(4)2
Avg EPS beat(4)-3.04%
Min EPS beat(4)-14.2%
Max EPS beat(4)4.12%
EPS beat(8)5
Avg EPS beat(8)-1%
EPS beat(12)8
Avg EPS beat(12)-0.08%
EPS beat(16)11
Avg EPS beat(16)0.72%
Revenue beat(2)2
Avg Revenue beat(2)2.87%
Min Revenue beat(2)1.45%
Max Revenue beat(2)4.3%
Revenue beat(4)3
Avg Revenue beat(4)1.78%
Min Revenue beat(4)-0.71%
Max Revenue beat(4)4.3%
Revenue beat(8)3
Avg Revenue beat(8)0.42%
Revenue beat(12)6
Avg Revenue beat(12)0.84%
Revenue beat(16)9
Avg Revenue beat(16)0.69%
PT rev (1m)-22.48%
PT rev (3m)-26.56%
EPS NQ rev (1m)-0.07%
EPS NQ rev (3m)-42.6%
EPS NY rev (1m)-13.1%
EPS NY rev (3m)-13.15%
Revenue NQ rev (1m)-0.02%
Revenue NQ rev (3m)0.48%
Revenue NY rev (1m)0.09%
Revenue NY rev (3m)1.15%
Valuation
Industry RankSector Rank
PE 9.58
Fwd PE 9.93
P/S 0.38
P/FCF 13.46
P/OCF 11.11
P/B 1.63
P/tB 18.43
EV/EBITDA 8.87
EPS(TTM)33.02
EY10.44%
EPS(NY)31.86
Fwd EY10.07%
FCF(TTM)23.5
FCFY7.43%
OCF(TTM)28.46
OCFY9%
SpS840.46
BVpS194.16
TBVpS17.16
PEG (NY)N/A
PEG (5Y)0.86
Profitability
Industry RankSector Rank
ROA 4.4%
ROE 12.26%
ROCE 7.72%
ROIC 5.9%
ROICexc 6.38%
ROICexgc 11.77%
OM 4.6%
PM (TTM) 2.83%
GM N/A
FCFM 2.8%
ROA(3y)5.45%
ROA(5y)5.58%
ROE(3y)15.32%
ROE(5y)15.33%
ROIC(3y)6.9%
ROIC(5y)7.19%
ROICexc(3y)7.45%
ROICexc(5y)7.72%
ROICexgc(3y)13.9%
ROICexgc(5y)14.63%
ROCE(3y)9.03%
ROCE(5y)9.4%
ROICexcg growth 3Y-5.49%
ROICexcg growth 5Y-3.16%
ROICexc growth 3Y-5.02%
ROICexc growth 5Y-2.23%
OM growth 3Y-7.78%
OM growth 5Y-4.45%
PM growth 3Y-8.42%
PM growth 5Y-6.01%
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover1.55
Health
Industry RankSector Rank
Debt/Equity 0.65
Debt/FCF 5.7
Debt/EBITDA 2.8
Cap/Depr 75.47%
Cap/Sales 0.59%
Interest Coverage 250
Cash Conversion 62.96%
Profit Quality 98.73%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score5
WACC8.1%
ROIC/WACC0.73
Cap/Depr(3y)77.74%
Cap/Depr(5y)81.03%
Cap/Sales(3y)0.73%
Cap/Sales(5y)0.76%
Profit Quality(3y)103.66%
Profit Quality(5y)128.32%
High Growth Momentum
Growth
EPS 1Y (TTM)-6.64%
EPS 3Y8.28%
EPS 5Y11.17%
EPS Q2Q%-12.65%
EPS Next Y-8.42%
EPS Next 2Y-1.7%
EPS Next 3Y3.63%
EPS Next 5Y8.79%
Revenue 1Y (TTM)10.21%
Revenue growth 3Y8.44%
Revenue growth 5Y11.14%
Sales Q2Q%14.34%
Revenue Next Year12.27%
Revenue Next 2Y8.86%
Revenue Next 3Y7.89%
Revenue Next 5Y8.96%
EBIT growth 1Y-14.33%
EBIT growth 3Y0%
EBIT growth 5Y6.19%
EBIT Next Year-2.13%
EBIT Next 3Y3.18%
EBIT Next 5Y8.53%
FCF growth 1Y-49.94%
FCF growth 3Y-14.89%
FCF growth 5Y-2.08%
OCF growth 1Y-45.8%
OCF growth 3Y-11.78%
OCF growth 5Y-1.08%